Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd (SHA:600721)

SHA:600721 Revenue

Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd had revenue of 90.17M CNY in the quarter ending June 30, 2026, a decrease of -14.26%. This brings the company's revenue in the last twelve months to 343.59M, down -12.25% year-over-year. In the year 2025, Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd had annual revenue of 388.32M with 0.66% growth. That makes Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd the world's 27,785th largest company by revenue and 4,798th in China.

• Revenue (ttm): 343.59M
• Revenue Growth: -12.25%
• P/S Ratio: 14.67
• Revenue / Employee: 497.96K
• Employees: 690
• Market Cap: 4.90B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	388.32M	2.56M	0.66%
Dec 31, 2024	385.76M	16.48M	4.46%
Dec 31, 2023	369.28M	19.39M	5.54%
Dec 31, 2022	349.88M	68.53M	24.36%
Dec 31, 2021	281.35M	196.82M	232.84%

Data Source: S&P Global Market Intelligence Last updated: Aug 24, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 5, 2026

Data Sources Report a data error